Last updated: May 29, 2026

Application No. 17/772,374

COMPOSITION FOR SLEEP IMPROVEMENT COMPRISING ERGOTHIONEINE OR SALT THEREOF

Non-Final OA

Filed

Apr 27, 2022

Priority

Oct 28, 2019 — JP 2019-195440 +1 more

Examiner

MCMILLIAN, KARA RENITA

Art Unit

1623

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Suntory Holdings Limited

OA Round

2 (Non-Final)

This examiner grants 31% of cases after interview

— +37.9% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 958 resolved cases, 2023–2026

Examiner Intelligence

MCMILLIAN, KARA RENITA View full profile →

Grants only 31% of cases

Career Allowance Rate

293 granted / 958 resolved

-29.4% vs TC avg

Strong +38% interview lift

Without

With

+37.9%

Interview Lift

resolved cases with interview

Typical timeline

3y 8m

Avg Prosecution

54 currently pending

Career history

1024

Total Applications

across all art units

Statute-Specific Performance

§101

0.6%

-39.4% vs TC avg

§103

84.5%

+44.5% vs TC avg

§102

6.0%

-34.0% vs TC avg

§112

6.0%

-34.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 958 resolved cases

Prosecution Timeline

Apr 27, 2022

Application Filed

Mar 11, 2025

Non-Final Rejection mailed

Jun 10, 2025

Response Filed

Sep 10, 2025

Final Rejection mailed

Dec 10, 2025

Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

17/431,460

Patent 12637467

INHIBITOR OF BTK AND MUTANTS THEREOF

4y 9m to grant Granted May 26, 2026

17/755,084

Patent 12594270

Schizophrenic Disorder Treatment using Combination Therapy

3y 11m to grant Granted Apr 07, 2026

17/052,192

Patent 12583852

NOVEL HETEROCYCLE DERIVATIVE

5y 4m to grant Granted Mar 24, 2026

17/579,271

Patent 12558364

NEXT GENERATION REMDESIVIR ANTIVIRALS

4y 1m to grant Granted Feb 24, 2026

18/907,258

Patent 12533331

S-BETA-HYDROXYBUTYRIC ACID COMPOSITIONS AND METHODS FOR DELIVERY OF KETONE BODIES

1y 3m to grant Granted Jan 27, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3

Expected OA Rounds

31%

Grant Probability

68%

With Interview (+37.9%)

3y 8m (~0m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 958 resolved cases by this examiner. Grant probability derived from career allowance rate.